Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rosacea | 3 | 2019 | 46 | 1.330 |
Why?
|
| Skin Care | 2 | 2017 | 11 | 0.760 |
Why?
|
| Plant Extracts | 2 | 2018 | 60 | 0.640 |
Why?
|
| Dermatology | 4 | 2018 | 154 | 0.550 |
Why?
|
| Hypericum | 1 | 2014 | 2 | 0.500 |
Why?
|
| Herb-Drug Interactions | 1 | 2014 | 2 | 0.500 |
Why?
|
| Phytotherapy | 1 | 2014 | 38 | 0.490 |
Why?
|
| Complementary Therapies | 1 | 2014 | 75 | 0.450 |
Why?
|
| Arthritis, Psoriatic | 1 | 2009 | 25 | 0.340 |
Why?
|
| Affect | 1 | 2009 | 63 | 0.330 |
Why?
|
| Physician's Role | 1 | 2009 | 38 | 0.330 |
Why?
|
| Fibromyalgia | 1 | 2009 | 24 | 0.330 |
Why?
|
| Ultraviolet Therapy | 1 | 2009 | 39 | 0.330 |
Why?
|
| Office Visits | 1 | 2009 | 71 | 0.330 |
Why?
|
| Ambulatory Care | 1 | 2009 | 97 | 0.320 |
Why?
|
| Pain | 1 | 2009 | 282 | 0.280 |
Why?
|
| Eye Abnormalities | 1 | 2006 | 4 | 0.280 |
Why?
|
| Pterygium | 1 | 2006 | 4 | 0.280 |
Why?
|
| Humans | 21 | 2019 | 29213 | 0.260 |
Why?
|
| Medication Adherence | 3 | 2010 | 144 | 0.240 |
Why?
|
| Dermatitis, Atopic | 3 | 2010 | 86 | 0.240 |
Why?
|
| Transients and Migrants | 1 | 2006 | 281 | 0.220 |
Why?
|
| Hispanic Americans | 1 | 2006 | 904 | 0.180 |
Why?
|
| Acne Vulgaris | 2 | 2010 | 93 | 0.170 |
Why?
|
| Administration, Cutaneous | 1 | 2019 | 107 | 0.160 |
Why?
|
| Patient Compliance | 2 | 2010 | 212 | 0.150 |
Why?
|
| Wound Healing | 1 | 2018 | 182 | 0.150 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 43 | 0.150 |
Why?
|
| United States | 3 | 2014 | 3648 | 0.150 |
Why?
|
| Skin Diseases | 1 | 2018 | 138 | 0.150 |
Why?
|
| Pellagra | 1 | 2016 | 3 | 0.140 |
Why?
|
| Hand Dermatoses | 1 | 2016 | 10 | 0.140 |
Why?
|
| Exanthema | 1 | 2016 | 21 | 0.140 |
Why?
|
| Erythema | 1 | 2016 | 27 | 0.140 |
Why?
|
| Psoriasis | 2 | 2013 | 334 | 0.130 |
Why?
|
| Prescriptions | 1 | 2014 | 9 | 0.130 |
Why?
|
| Dermatologic Agents | 1 | 2017 | 208 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 169 | 0.120 |
Why?
|
| Antidepressive Agents | 1 | 2014 | 70 | 0.120 |
Why?
|
| Adult | 7 | 2016 | 8466 | 0.120 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 864 | 0.110 |
Why?
|
| Specialization | 1 | 2013 | 30 | 0.110 |
Why?
|
| Pruritus | 1 | 2013 | 58 | 0.110 |
Why?
|
| Sleep | 1 | 2013 | 87 | 0.110 |
Why?
|
| Fluocinonide | 1 | 2010 | 11 | 0.100 |
Why?
|
| Quality of Life | 3 | 2013 | 819 | 0.100 |
Why?
|
| Clindamycin | 1 | 2010 | 18 | 0.090 |
Why?
|
| Pemphigus | 1 | 2010 | 8 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 206 | 0.090 |
Why?
|
| Tretinoin | 1 | 2010 | 34 | 0.090 |
Why?
|
| Eczema | 1 | 2010 | 12 | 0.090 |
Why?
|
| Depression | 1 | 2013 | 383 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2010 | 149 | 0.090 |
Why?
|
| Patient Care Planning | 1 | 2010 | 53 | 0.090 |
Why?
|
| Rheumatology | 1 | 2009 | 7 | 0.090 |
Why?
|
| Sunbathing | 1 | 2009 | 6 | 0.090 |
Why?
|
| Relaxation | 1 | 2009 | 9 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2013 | 283 | 0.090 |
Why?
|
| Rheumatic Diseases | 1 | 2009 | 7 | 0.090 |
Why?
|
| Retrospective Studies | 2 | 2014 | 3121 | 0.080 |
Why?
|
| Behavior, Addictive | 1 | 2009 | 31 | 0.080 |
Why?
|
| Antirheumatic Agents | 1 | 2009 | 27 | 0.080 |
Why?
|
| Early Diagnosis | 1 | 2009 | 61 | 0.080 |
Why?
|
| Arthralgia | 1 | 2009 | 31 | 0.080 |
Why?
|
| Pigmentation Disorders | 1 | 2008 | 8 | 0.080 |
Why?
|
| Fatigue | 1 | 2009 | 69 | 0.080 |
Why?
|
| Health Surveys | 1 | 2009 | 191 | 0.080 |
Why?
|
| Pediatrics | 1 | 2010 | 132 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2010 | 163 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 285 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2009 | 113 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2009 | 365 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2009 | 478 | 0.070 |
Why?
|
| Self Care | 1 | 2008 | 137 | 0.070 |
Why?
|
| Middle Aged | 5 | 2013 | 10868 | 0.070 |
Why?
|
| Female | 7 | 2016 | 18236 | 0.070 |
Why?
|
| North Carolina | 2 | 2008 | 1424 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2006 | 119 | 0.060 |
Why?
|
| Male | 7 | 2013 | 17872 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 724 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2010 | 3108 | 0.050 |
Why?
|
| Croton | 1 | 2018 | 2 | 0.040 |
Why?
|
| Child | 3 | 2010 | 2221 | 0.040 |
Why?
|
| Aged | 3 | 2013 | 9510 | 0.030 |
Why?
|
| Surgery, Plastic | 1 | 2013 | 26 | 0.030 |
Why?
|
| Otolaryngology | 1 | 2013 | 17 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 53 | 0.030 |
Why?
|
| Adolescent | 2 | 2010 | 3265 | 0.030 |
Why?
|
| Internal Medicine | 1 | 2013 | 45 | 0.030 |
Why?
|
| General Surgery | 1 | 2013 | 81 | 0.030 |
Why?
|
| Logistic Models | 1 | 2013 | 729 | 0.020 |
Why?
|
| Gels | 1 | 2010 | 33 | 0.020 |
Why?
|
| Mycophenolic Acid | 1 | 2010 | 28 | 0.020 |
Why?
|
| Remission Induction | 1 | 2010 | 78 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 860 | 0.020 |
Why?
|
| Prednisone | 1 | 2010 | 43 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 129 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2010 | 130 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 273 | 0.020 |
Why?
|
| Lentigo | 1 | 2008 | 4 | 0.020 |
Why?
|
| Vitiligo | 1 | 2008 | 4 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 525 | 0.020 |
Why?
|
| Melanosis | 1 | 2008 | 13 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2008 | 40 | 0.020 |
Why?
|
| Hyperpigmentation | 1 | 2008 | 17 | 0.020 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2009 | 53 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2008 | 35 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2008 | 23 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2008 | 64 | 0.020 |
Why?
|
| Biological Therapy | 1 | 2008 | 20 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2008 | 95 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2008 | 111 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 7302 | 0.020 |
Why?
|
| Models, Biological | 1 | 2009 | 373 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 208 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 252 | 0.020 |
Why?
|
| Prevalence | 1 | 2008 | 907 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 2003 | 0.020 |
Why?
|
| Asthma | 1 | 2008 | 397 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2008 | 1694 | 0.020 |
Why?
|
| Young Adult | 1 | 2010 | 2413 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2008 | 2027 | 0.010 |
Why?
|